Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Brief Commentary
Cardio Oncology with ACOS
Case Report
Case Series
Conference Review
Consensus Statement
Current Issue
Editorial
Erratum
Letter to Editor
Media and News
Molecular Insight Story
New Drug Update
News
Original Article
Position Paper
Response to the letter
Review Article
Short Communication
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Brief Commentary
Cardio Oncology with ACOS
Case Report
Case Series
Conference Review
Consensus Statement
Current Issue
Editorial
Erratum
Letter to Editor
Media and News
Molecular Insight Story
New Drug Update
News
Original Article
Position Paper
Response to the letter
Review Article
Short Communication

Most Viewed Articles


Articles Fulltext downloads PDF downloads Total downloads
Short Communication
Driver mutations in oncogenesis
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 2, May-August
DOI: 10.25259/IJMIO_26_2020
25,590 2,725 28,315
Review Article
Mini review: Molecular pathology of personalized medicine in cancer susceptibility syndromes
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 3, September-December
DOI: 10.25259/IJMIO_12_2023
18,387 1,600 19,987
Short Communication
Outcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in Bangladesh
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 1, January-April
DOI: 10.25259/IJMIO_30_2020
17,559 2,316 19,875
Original Article
Outcomes with atezolizumab and bevacizumab in hepatocellular carcinoma – Real-world data from India
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 3, September-December
DOI: 10.25259/IJMIO_15_2023
17,315 1,434 18,749
Editorial
Challenging conventional wisdom in molecular oncology: New perspectives
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 3, September-December
DOI: 10.25259/IJMIO_20_2023
17,355 1,379 18,734
Review Article
Molecular oncology and the role of artificial intelligence in advancing cancer treatment
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 3, September-December
DOI: 10.25259/IJMIO_17_2023
17,202 952 18,154
News
Editorial board tribute to Dr. Amit Verma
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
14,457 1,688 16,145
Review Article
Can CDK 4/6 inhibitors be used in patients with visceral crises? Deviating from conventional teaching
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 2, May – August
DOI: 10.25259/IJMIO_8_2022
11,923 4,007 15,930
Case Report
Clinical experience of total body irradiation performed on Halcyon™ for a patient diagnosed with acute myeloid leukemia
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 2, May – August
DOI: 10.25259/IJMIO_5_2022
11,016 4,656 15,672
Case Report
Squamous cell carcinoma of lung presenting as “Sunray sign” in chest radiograph
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 3, September-December
DOI: 10.25259/IJMIO_6_2023
13,618 1,479 15,097
Case Report
Long-term efficacy of osimertinib in de novo exon 19 deletion with T790M in an epidermal growth factor receptor mutated lung cancer patient in India
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2024, Volume: 9, Issue: 1, January-April
DOI: 10.25259/IJMIO_16_2023
13,733 1,129 14,862
Case Report
Hyperthermic intraperitoneal chemotherapy in primary peritoneal cancer: Our experience in a young male
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI: 10.25259/IJMIO_16_2021
13,301 1,509 14,810
Review Article
Potential therapeutic molecular targets for better outcomes for patients with lung cancer
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 2, May-August
DOI: 10.25259/IJMIO_27_2022
14,098 535 14,633
New Drug Update
Amlodipine-induced inhibition of NFAT-2 nuclear translocation and its utility as an additive to immune checkpoint inhibitor
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI: 10.25259/IJMIO_13_2021
13,137 1,488 14,625
Review Article
Combination of PARPi and anti-PD-L1 therapies in ovarian cancer
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 2, May-August
DOI: 10.25259/IJMIO_28_2022
13,891 678 14,569
Cardio Oncology with ACOS
Ibrutinib and atrial fibrillation as cardiotoxicity – A new safety warning that impacts overall survival
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 2, May – August
DOI: 10.25259/IJMIO_1_2022
11,016 3,469 14,485
Review Article
Signaling pathways in pancreatic ductile adenocarcinoma and potential therapeutic targets
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 3, September-December
DOI: 10.25259/IJMIO_29_2022
13,102 1,232 14,334
Original Article
Incorporation of immunohistochemistry in the assessment of survival and prognosis of endometrial cancers: Are we ready for the change?
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 2, May – August
DOI: 10.25259/IJMIO_2_2022
10,601 3,528 14,129
Review Article
Immune dynamics of SARS-CoV-2 virus evolution
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 1, January-April
DOI: 10.25259/IJMIO_26_2021
9,759 3,749 13,508
Case Series
Dual driver in non-small cell lung carcinoma – therapeutic dilemma
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 1, January-April
DOI: 10.25259/IJMIO_22_2021
11,522 1,824 13,346
Review Article
Advances in immunotherapy for metastatic esophageal cancer
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 3, September-December
DOI: 10.25259/IJMIO_14_2022
9,459 3,451 12,910
Case Report
L1CAM expressing, ZFTA:: NCOA1 fusion-positive supratentorial ependymoma: A case report
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 3, September-December
DOI: 10.25259/IJMIO_11_2023
12,045 781 12,826
Review Article
Immuno-oncological era of breast cancer: A progressive path to better treatment
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 2, May – August
DOI: 10.25259/IJMIO_3_2022
8,349 4,441 12,790
Review Article
Is continuous infusion of high-dose ifosfamide, a safe option? Drug review
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 2, May-August
DOI: 10.25259/IJMIO_21_2019
10,115 2,634 12,749
Case Report
Redefining the treatment of metastatic uveal melanoma with immunotherapy – A case report
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 2, May – August
DOI: 10.25259/IJMIO_11_2022
10,463 2,171 12,634
Review Article
The evolving role of precision medicine in the management of advanced sarcomas – A mini review
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI: 10.25259/IJMIO_6_2021
10,851 1,781 12,632
Editorial
Nanobytes
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 3, September-December
DOI: 10.25259/IJMIO_7_2019
6,193 6,388 12,581
Review Article
Post-chemotherapy maintenance treatment by nicotinamide riboside, a poly ADP ribose polymerase 1 inhibitor, in BRCA mutated advanced ovarian cancer – A perspective
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI: 10.25259/IJMIO_12_2021
10,390 1,971 12,361
Conference Review
6th Molecular Oncology Society Conference: Improving patient survival by molecularly targeted therapies
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI: 10.25259/IJMIO_20_2021
10,766 1,411 12,177
Erratum
Erratum for manuscript “Muir Torre Syndrome – An Indian Case report” (IJMIO_5_2020)
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 2, October
DOI: 10.25259/IJMIO_05_2020_ER
11,060 961 12,021
Review Article
Immuno-oncology of differentiated thyroid cancer
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 2, May-August
DOI: 10.25259/IJMIO_36_2020
9,582 2,435 12,017
Brief Commentary
ERBB and FGFR2 pathway inhibition in biliary tract cancers – Dawn of a new beginning
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI: 10.25259/IJMIO_10_2021
10,040 1,932 11,972
Case Report
Complete metabolic response with letrozole and palbociclib in advanced breast cancer
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 3, September-December
DOI: 10.25259/IJMIO_2_2019
7,506 4,293 11,799
Case Report
Unusual presentation of an Epstein barr virus-negative extranodal natural killer/T cell lymphoma: A diagnostic dilemma
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 1, January-April
DOI: 10.25259/IJMIO_18_2021
10,253 1,527 11,780
Review Article
A compendium of population wide DNA methylation profile for oral cancer in India
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 2, May-August
DOI: 10.25259/IJMIO_2_2021
8,982 2,781 11,763
Brief Commentary
Breast cancer prognostic tools: A promising Indian option
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 2, May-August
DOI: 10.25259/IJMIO_15_2020
7,877 3,509 11,386
Letter to Editor
Letter to editor
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 2, May – August
DOI: 10.25259/IJMIO_10_2022
7,722 3,452 11,174
Brief Commentary
Bioactive lipid: A novel diagnostic approach for retinoblastoma in clinical management
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI: 10.25259/IJMIO_7_2021
9,229 1,940 11,169
Case Report
Metastatic endometrial carcinoma responsive to pembrolizumab
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 1, January-April
DOI: 10.25259/IJMIO_18_2020
6,344 4,687 11,031
Review Article
Resistance to poly ADP-ribose polymerase inhibitors and its clinical implications
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 2, May – August
DOI: 10.25259/IJMIO_12_2022
6,984 3,947 10,931
Review Article
Cell biological basis of tumor relapse and recurrence – A help from yeast quiescent biology and neuronal quiescent cell biology
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 1, January-April
DOI: 10.25259/IJMIO_18_2019
6,013 4,907 10,920
Review Article
Impact of 2013 ASCO/CAP guidelines on various HER2 reporting categories in breast cancer by fluorescent in-situ hybridization and Immunohistochemistry: A meta-analysis with systematic review
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 1, January-April
DOI: 10.25259/IJMIO_17_2019
5,532 5,230 10,762
Review Article
The Cancer Genomic Atlas – “TO CONQUER CANCER”
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 2, May-August
DOI: 10.25259/IJMIO_28_2020
8,462 2,249 10,711
Original Article
Real World Outcomes of Check Point Inhibitors Immunotherapy in Renal and Urothelial Cancers in a Teratiary Care Cancer Center in India
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 3, September-December
DOI: 10.25259/IJMIO_1_2019
5,084 5,607 10,691
Review Article
Molecular genetics changes in gallbladder carcinoma
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 2, May-August
DOI: 10.25259/IJMIO_19_2019
7,230 3,129 10,359
Case Report
A rare case of Exon 19 deletion transforming to Exon 20 insertion in a case of adenocarcinoma of lung
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 3, September-December
DOI: 10.25259/IJMIO_13_2022
8,473 1,873 10,346
Editorial
Molecular insights into tumor microenvironment and targeted therapies
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 1, January-April
DOI: 10.25259/IJMIO_28_2021
7,629 2,279 9,908
Editorial
Immune checkpoint inhibitor – antiangiogenic drugs combination in treatment-naïve metastatic clear cell renal cell carcinoma: Why should immunotherapy have all the fun!
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 1, January-April
DOI: 10.25259/IJMIO_23_2019
5,174 4,726 9,900
Position Paper
Practical consensus recommendations – Current role of immune response evaluation criteria in solid tumors criteria in the management of cancer patients receiving immunotherapy
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 1, January-April
DOI: 10.25259/IJMIO-6-2019
5,459 4,373 9,832
Original Article
Advanced lung cancer and molecular testing in the middle of coronavirus disease 2019 second wave in the South Asian association for regional cooperation region
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 2, May-August
DOI: 10.25259/IJMIO_15_2021
7,293 2,472 9,765